MarketPeel
Insider Trading Intelligence
CJ

Cassie Jung

AQST
SVP, OPERATIONS · AQUESTIVE THERAPEUTICS, INC. · CIK 0001960154
FILING MIX · LIFETIME48%/52%
BUYS
13
SELLS
14
TOTAL VALUE
$1.62M
COMPANIES
1
ACTIVE SINCE
Mar 2023
HOLDINGS NOW
202,246
AVG SELL PX
$4.98
TRADE KIND
SHOWING 27 / 27
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 8 pending
Forward-return performance of every backtestable P/S trade by Cassie Jung, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+100.00%-5.29%+0.33%-5.62%-5.35%
14d4+100.00%-10.86%+0.55%-11.40%-9.73%
30d4+75.00%-9.41%+1.24%-10.66%-13.29%
60d4+50.00%-6.26%+4.52%-10.79%-13.95%
90d4+75.00%-19.38%+4.58%-23.96%-27.16%
180d4(1 pending)+100.00%-37.78%+1.66%-39.44%-46.06%
1y4(3 pending)+0.00%+27.46%+13.88%+13.58%+13.58%
2y4(4 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AQST · 202,246 shares · as of May 5, 2026
086,382172,763259,145345,526202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 13 buys / 14 sellsCOVERAGE · 14 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
Chief Operating Officer
72,734$4.18$304.0K202,246May 5, 2026May 7, 2026View →
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
Chief Operating Officer
45,791$4.17$191.1K274,980Mar 10, 2026Mar 11, 2026View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
80,000320,771Mar 9, 2026Mar 11, 2026View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
42,50042,500Mar 9, 2026Mar 11, 2026View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
25,000$3.10$77.6K308,346Oct 15, 2025Oct 16, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
Chief Operating Officer
25,0000Oct 15, 2025Oct 16, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
67,575$7.01$473.7K240,771Oct 15, 2025Oct 16, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
62,180$5.00$310.9K283,346Sep 4, 2025Sep 8, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
25,000$0.71$17.7K345,526Sep 4, 2025Sep 8, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
25,000$3.15$78.8K320,526Sep 4, 2025Sep 8, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
Chief Operating Officer
25,0000Sep 4, 2025Sep 8, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,182$2.54$5.5K295,526Mar 10, 2025Mar 11, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
Chief Operating Officer
7,997$2.65$21.2K297,708Mar 9, 2025Mar 11, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
80,000313,066Mar 7, 2025Mar 11, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Mar 7, 2025Mar 11, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
60,00060,000Mar 7, 2025Apr 13, 2026View →
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
Chief Operating Officer
7,361$2.65$19.5K305,705Mar 7, 2025Mar 11, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
Chief Operating Officer
44$4.87$2140Nov 26, 2024Nov 27, 2024View →
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
SVP, Operations
1,132$4.88$5.5K237,754Mar 10, 2024Mar 12, 2024View →
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
SVP, Operations
8,300$4.88$40.5K238,886Mar 9, 2024Mar 12, 2024View →
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
SVP, Operations
14,120$4.88$68.9K233,066Mar 9, 2024Oct 2, 2024View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
101,250247,186Mar 7, 2024Mar 11, 2024View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
50,62550,625Mar 7, 2024Mar 11, 2024View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
55,00055,000Aug 9, 2023Aug 9, 2023View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
55,00055,000May 5, 2023May 9, 2023View →
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
SVP, Operations
1,365145,936Mar 10, 2023Mar 11, 2024View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
110,000146,747Mar 9, 2023Mar 9, 2023View →
Other insiders · AQST
Loading peer insiders…
About this filer
CIK 0001960154
ROLE
SVP, Operations
PRIMARY
AQST
COMPANIES
1
ACTIVE SINCE
Mar 2023
MARKETPEEL · /INSIDER/0001960154DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback